Jessica is active in all aspects of trademark law, including domestic and international trademark portfolio management. Jessica routinely counsels clients on global trademark clearance, protection and enforcement strategies. An integral part of her practice, Jessica counsels clients on U.S. and foreign trademark opposition and cancellation proceedings and assists clients with preparing and responding to cease and desist letters.
Jessica advises clients on copyright matters, including filing applications and analyzing license agreements. She also has handled UDRP proceedings before the National Arbitration Forum and has advised clients on IP diligence matters.
Jessica also has extensive experience with trademark and copyright litigations and patent and trade secret litigation involving the computer, electrical, mechanical and pharmaceutical arts. Some of the technologies she has worked with include computer hardware and software, electronic commerce and trading systems, injection molding systems and processes, ophthalmic lens manufacturing processes, laser printing, hormone replacement therapy, oral contraceptives and antibacterial ear drops.
The Dreyfus Corporation and MBSC Securities Corporation
Successfully represented The Dreyfus Corporation and MBSC Securities Corporation in a proceeding brought before the National Arbitration Forum pursuant to ICANN’s Uniform Domain Name Dispute Resolution Policy. The respondents in the proceeding used false aliases to register the dreyfuscorp.com and dreyfus-corp.com domain names and then used those domain names to pass themselves off as representatives of The Dreyfus Corporation to induce individuals into revealing private financial information, undoubtedly for financial gain. The National Arbitration Forum panel will transfer the dreyfuscorp.com and dreyfus-corp.com domain names to The Dreyfus Corporation and MBSC Securities Corporation and concluded that: (1) the Dreyfus Corporation and MBSC Securities Corporation had established rights to its DREYFUS FUNDS INC trademark; (2) that the dreyfuscorp.com and dreyfus-corp.com domain names are confusingly similar to DREYFUS FUNDS INC; (3) that respondents had no rights or legitimate interests in the domain names; and (4) that respondents use of the domain names constituted bad faith registration and use.